-
Upcoming events
DCVA & RegMed XB Community Event
For academic researchers and healthcare innovators interested in valorization, entrepreneurship, and accelerating from lab to patient.
read more
RegMed XB Annual Conference 2026
Be part of the 4th RegMed XB Annual Conference: Collaborate to Regenerate. Get inspired and expand your network within the regenerative medicine field.
read more -
Expertise
Infrastructure: RegMed XB's Pilot Factory
A seamless pathway for innovators to accelerate, de-risk, and scale regenerative therapies
read more
-
Latest news
RegMed XB Referenced in Wennink Report on the Future of Life Sciences & Biotechnology in the Netherlands
The in December 2025 published independent advisory report chaired by Peter Wennink translates the findings of the Draghi report on Europe’s future earning capacity to the Dutch context.
read more
Strengthening the RegMed XB Flemish–Dutch Advanced Therapy Medicinal Products (ATMPs) ecosystem
RegMed XB proudly contributes to ATMP XB, a €3.5 million Interreg-cofunded initiative led by Biovia, aimed at reinforcing the cross-border ecosystem for ATMPs in Flanders and the South of the Netherlands.
read more
Eight National Growth Fund initiatives join forces to strengthen the Dutch Life Sciences & Health ecosystem
Eight initiatives funded through the Dutch National Growth Fund are joining forces to accelerate Life Sciences & Health innovation and sustainable economic growth, with a focus on societal impact in The Netherlands.
read more -
Moonshots (research excellence)
-
Pilot Factory (infrastructure)
The RegMed XB Pilot Factory is one of the largest international infrastructures for regenerative medicine. It brings together all the expertise and infrastructure needed to bring regenerative medicine to the market.
-
RegMed XB's Ecosystem
Health Foundations
The following Dutch health foundations are involved in defining research objectives and provide guidance in the research we conduct to ensure we maintain focus on the patient.
read moreAcademic Partners
RegMed XB works together with (inter)national top-rated academic institutions and collaborates specifically and exclusively with researchers who contribute specific expertise to the Moonshot initiatives.
read moreIndustrial Partners
Partnering with companies offers access to their expertise in designing scalable and feasible products. Currently, we have strong partnerships with the following entities.
read moreGovernmental Partners
RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.
read moreLife Science & Health partners
The following Life Science & Health (LSH) partners are collaborate with RegMed XB.
read more -
-
-
-
-
-
-
-
-
